CompoAtlas

Metamucil Fibre Therapy Clear Fibre Blend

Metamucil Fibre Therapy Clear Fibre Blend, NPN 80142618: natural health product licensed in Canada. Medicinal ingredients: Maltodextrines résistantes.

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Maltodextrines résistantes

Source : Zea mays - Graine

Potency : 2.45 g Fiber

2.72 gNot calculated

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Portions3 Tous les jours

Uses authorised in Canada

Source of fibre for the maintenance of good health. Helps support and maintain a healthy digestive system. Helps stimulate the growth of healthy bacteria (such as bifidobacteria) in the intestine/gut. Prebiotic. Helps provide gentle relief of constipation and/or irregularity.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Other names
Metamucil Clear Fibre Blend, Metamucil Fibre Blend
Licence holder
Procter & Gamble Inc.
NPN or DIN-HM
80142618
Status
Active licence
Licence date
15 July 2025
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80142618

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Metamucil Fibre Therapy Clear Fibre Blend (Procter & Gamble Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80142618-metamucil-fibre-therapy-clear-fibre-blend, updated 15 July 2025.

Enter to analyse, Shift+Enter for a new line